Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01367899 · ClinicalTrials.gov registry record
CONSERVE Plus Post-Approval Study (PAS)
A clinical trial, sponsored by MicroPort Orthopedics.
- Terminated
- Registry status
- 199
- Enrollment target
NCT01367899: Clinical Trial study, sponsored by MicroPort Orthopedics.
NCT01367899 is a clinical trial that was terminated before completion, run by MicroPort Orthopedics. The registered enrollment target is 199 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01367899 was terminated before completion, sponsored by MicroPort Orthopedics.
- TERMINATED
- Registry status
- 199 participants
- Enrollment target
Study Summary
The objective of this post-approval study is to provide scientifically valid and reliable evidence that supports claims of longer term safety and effectiveness with regard to Month 120 device survivorship rates.
Primary Outcome
Clinical success at Month 120 for each patient will be survivorship, defined as freedom from revision or removal for any aseptic reason and at least "good" function/pain relief defined as Harris Hip Score ≥ 80.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2010-11 |
| Est. Completion | 2014-09 |
Why NCT01367899 stopped before completion
NCT01367899 is an observational study that tracks outcomes without assigning an intervention. The registered 199 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01367899 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01367899 about?
NCT01367899 is a clinical study titled "CONSERVE Plus Post-Approval Study (PAS)". The objective of this post-approval study is to provide scientifically valid and reliable evidence that supports claims of longer term safety and effectiveness with regard to Month 120 device survivorship rates.
What is the current status of trial NCT01367899?
This trial is currently terminated. The enrollment target is 199 participants. The study started on 2010-11. Estimated completion is 2014-09.
Who is sponsoring clinical trial NCT01367899?
This trial is sponsored by MicroPort Orthopedics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04312126 · 199 participants
The Beneficial Effects of Naps on Motor Learning
- NCT04951622 · 199 participants · Phase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- NCT06474533 · 199 participants
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia